Top Markets
Coin of the day
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
Rangering i aksjer #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Aksjekurs
$1.96
Sist synkronisert: 2022-09-20
Markedsverdi
$4.46M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Imunon, Inc. (CLSN)

Kategori

Aksjeprishistorikk for Imunon, Inc. (CLSN)
Høyeste sluttskurs: $2.07 den 2022-09-01

Laveste sluttskurs: $3.32K den 2008-06-01
Aksjeprishistorikk for Imunon, Inc. fra 2008 til 2026
Årlig aksjeprisytelse
År Ytelse
2022 -76.70%
2021 -7.06%
2020 -56.43%
2019 -9.75%
2018 -34.36%
2017 -62.92%
2016 -73.54%
2015 -19.45%
2014 -37.80%
2013 -89.21%
2012 314.30%
2011 -19.63%
2010 -19.31%
2009 14.94%
2008 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE